Your browser is no longer supported. Please, upgrade your browser.
ZOM Zomedica Pharmaceuticals Corp. daily Stock Chart
Zomedica Pharmaceuticals Corp.
Index- P/E- EPS (ttm)-0.19 Insider Own48.40% Shs Outstand129.17M Perf Week16.81%
Market Cap24.50M Forward P/E- EPS next Y-0.03 Insider Trans0.00% Shs Float66.50M Perf Month-7.46%
Income-19.80M PEG- EPS next Q- Inst Own0.50% Short Float1.82% Perf Quarter-42.36%
Sales- P/S- EPS this Y-4.50% Inst Trans-21.03% Short Ratio0.16 Perf Half Y-48.98%
Book/sh-0.09 P/B- EPS next Y57.10% ROA-302.40% Target Price- Perf Year-40.27%
Cash/sh0.00 P/C49.01 EPS next 5Y- ROE344.80% 52W Range0.12 - 0.50 Perf YTD-42.69%
Dividend- P/FCF- EPS past 5Y-28.50% ROI- 52W High-66.23% Beta0.39
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin- 52W Low40.42% ATR0.05
Employees28 Current Ratio0.90 Sales Q/Q- Oper. Margin- RSI (14)45.61 Volatility19.90% 24.16%
OptionableNo Debt/Eq- EPS Q/Q69.80% Profit Margin- Rel Volume0.49 Prev Close0.19
ShortableYes LT Debt/Eq- EarningsFeb 25 Payout- Avg Volume7.58M Price0.17
Recom2.00 SMA20-11.81% SMA50-20.26% SMA200-42.00% Volume2,203,202 Change-11.18%
Feb-26-20 05:25PM  Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results GlobeNewswire -18.76%
Feb-14-20 04:15PM  Zomedica Announces Completion of $2.5 Million Registered Direct Offering GlobeNewswire
Feb-12-20 08:43AM  Zomedica Announces $2.5 Million Registered Direct Offering GlobeNewswire -35.74%
Feb-11-20 06:55AM  Zomedica Files U.S. Patent Application for Fecal Parasite Detection GlobeNewswire +13.17%
Jan-30-20 06:55AM  Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020 GlobeNewswire
Jan-23-20 06:55AM  Zomedica to Focus on TRUFORMA Commercialization GlobeNewswire
Jan-20-20 06:55AM  Zomedica Successfully Completes Development and Manufacturing Milestones for its Cancer Liquid Biopsy Platform GlobeNewswire
Dec-23-19 04:00PM  Hedge Funds Have Never Been This Bullish On Zomedica Pharmaceuticals Corp. (ZOM) Insider Monkey +5.26%
Dec-03-19 06:55AM  Zomedica Announces Management Changes GlobeNewswire
Nov-13-19 06:55AM  Zomedica Expands ZM-006 Pilot Efficacy Study GlobeNewswire
Nov-12-19 04:53PM  Zomedica Announces Third Quarter 2019 Financial Results GlobeNewswire
Nov-05-19 04:15PM  Zomedica Announces 2019 Annual Meeting Results GlobeNewswire
Oct-31-19 06:55AM  Zomedica Commences Final TRUFORMA Diagnostic Verification Study GlobeNewswire
Oct-03-19 11:27AM  CORRECTION FROM SOURCE: Zomedica Pushes TRUFORMA(TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market Newsfile
Oct-01-19 09:17AM  Zomedica Pushes TRUFORMA (TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market Newsfile -11.14%
Sep-18-19 01:39PM  Do Insiders Own Shares In Zomedica Pharmaceuticals Corp. (CVE:ZOM)? Simply Wall St.
Sep-17-19 06:55AM  Zomedica names Dr. Stephanie Morley President GlobeNewswire
Sep-11-19 09:09AM  PCG Research Announces Publication of Report Covering Zomedica Pharmaceuticals Corp. Newsfile +17.33%
09:00AM  Zomedica to Present at the Fall Investor Summit on Monday, September 16 in New York City ACCESSWIRE
Sep-03-19 06:55AM  Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference GlobeNewswire
Aug-19-19 06:55AM  Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors GlobeNewswire
Aug-13-19 08:00AM  Zomedica Inc. Prepares to Launch Veterinarian Diagnostic Device, TRUFORMA(TM); Has Potential to Change Diagnostic Landscape in Animal Health (NYSE American: ZOM) ACCESSWIRE
Aug-08-19 04:08PM  Zomedica Announces Second Quarter 2019 Financial Results GlobeNewswire
Aug-07-19 06:55AM  Zomedica Announces TRUFORMA Assay Updates and R&D Expansion GlobeNewswire
Jul-25-19 06:55AM  Zomedicas Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4 GlobeNewswire
Jul-17-19 06:55AM  Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline GlobeNewswire
Jun-26-19 10:05AM  ZOM: One Instrument; Multiple Solutions Zacks Small Cap Research
Jun-13-19 06:55AM  Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform GlobeNewswire +10.20%
Jun-12-19 04:35PM  Zomedica to Present at Raymond James Life Sciences and MedTech Conference GlobeNewswire -13.05%
Jun-10-19 06:00AM  Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares GlobeNewswire +6.57%
May-21-19 06:55AM  Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA Point-of-Care Diagnostic Platform GlobeNewswire +12.96%
May-10-19 05:21PM  Zomedica Announces First Quarter 2019 Financial Results GlobeNewswire +6.69%
06:00AM  Zomedica Announces Private Placement of Preferred Shares GlobeNewswire
Mar-26-19 06:00AM  Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares GlobeNewswire -43.82%
Mar-25-19 04:01PM  Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares GlobeNewswire -12.38%
Mar-05-19 06:55AM  Zomedica Initiates ZM-006 Pilot Efficacy Study and Provides Corporate Updates GlobeNewswire +6.77%
Feb-26-19 04:05PM  Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results GlobeNewswire
Jan-15-19 06:55AM  Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs GlobeNewswire +5.36%
Jan-14-19 06:55AM  Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update GlobeNewswire -7.44%
Dec-20-18 05:23PM  Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program GlobeNewswire +9.32%
Dec-19-18 06:00AM  IncellDx and Zomedica Sign Diagnostic CTC Assay Development Agreement for Canine Cancer PR Newswire -13.87%
Nov-28-18 09:53AM  Qorvo, Zomedica Tie-Up to Enhance Vet Health with BAW Sensors Zacks +12.34%
Nov-27-18 06:51AM  Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform GlobeNewswire -10.47%
06:50AM  Zomedica Announces $10 Million Private Offering of Common Shares GlobeNewswire
Nov-26-18 07:25AM  Analysis: Positioning to Benefit within Dominion Energy Midstream Partners, LP, Blue Capital Reinsurance, CRH Medical, Friedman Industries, CM Finance, and Zomedica Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +11.69%
Nov-13-18 04:47PM  Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results GlobeNewswire -5.17%
Nov-12-18 04:30PM  Zomedica Pharmaceuticals Corp. to Present at Jefferies 2018 London Healthcare Conference and LD Micro Main Event XI GlobeNewswire
Oct-16-18 09:00AM  SeeThruEquity Issues Update on Zomedica Pharmaceuticals Corp. ACCESSWIRE
Sep-18-18 06:55AM  Zomedica Pharmaceuticals Corp. to Present at LD Micro NYC Summit and Cantor 2018 Global Healthcare Conference GlobeNewswire
Aug-15-18 04:15PM  Zomedica Announces 2018 Annual Meeting Results GlobeNewswire
Aug-09-18 04:01PM  Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results GlobeNewswire
Jun-28-18 08:57PM  Zomedica Announces Interim Closing and Extension of Its Private Offering of Common Shares GlobeNewswire
Jun-25-18 05:59PM  Zomedica Joins Russell 3000 and Russell Microcap® Indexes GlobeNewswire -15.77%
Jun-19-18 06:54AM  Zomedica Provides Product Development Update GlobeNewswire
Jun-14-18 06:15PM  Zomedica Announces Changes to Commercialization Leadership Team GlobeNewswire
May-15-18 04:06PM  Zomedica Pharmaceuticals Corp. Announces First Quarter 2018 Financial Results GlobeNewswire
04:01PM  Zomedica Announces Up to $10 Million Private Offering of Common Shares GlobeNewswire
May-14-18 07:30AM  Wired News Zomedica Inks Deal with Seraph to Develop and Market Seraphs Novel Pathogen Detection System for Veterinarians ACCESSWIRE -5.00%
May-10-18 06:55AM  Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic GlobeNewswire
May-07-18 06:55AM  Zomedica to Present at 2018 Disruptive Growth & Healthcare Conference GlobeNewswire
Mar-26-18 09:00AM  SeeThruEquity Issues Update on Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) ACCESSWIRE
Mar-07-18 06:55AM  Zomedica to Present at 30th Annual ROTH Conference GlobeNewswire
Feb-28-18 04:11PM  Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results GlobeNewswire
Feb-20-18 06:55AM  Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit GlobeNewswire
Dec-01-17 09:00AM  SeeThruEquity Initiates Coverage on Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) with a Price Target of $3.24 ACCESSWIRE
Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan.